Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNK.L Regulatory News (DNK)

  • There is currently no data for DNK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Shares and Appendix 3B

9 Oct 2019 07:00

RNS Number : 1878P
Danakali Limited
09 October 2019
 

Announcement

Wednesday, 9 October 2019

 

Issue of shares

 

Danakali Limited (ASX: DNK / LSE: DNK) (Danakali, or the Company) is pleased to announce that it has raised A$135,750 through the issue of 250,000 new fully paid shares upon the exercise of unlisted options. A further 15,000 new fully paid shares were issued to an employee on the vesting of performance rights.

 

A completed Appendix 3B has been lodged together with this announcement.

 

Secondary Trading Exemption - s708A Notice

 

Danakali gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Act) of the following:

·; The shares were issued without disclosure under Part 6D 2 of the Act;

·; This notice is being given under section 708A(5)(e) of the Act;

·; As at the date of this notice, the Company has complied with:

The provisions of Chapter 2M of the Act as they apply to the Company; and

Section 674 of the Act; and

·; As at the date of this notice, there is no information:

That has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and

That investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:

o The assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or

o The rights and liabilities attaching to the shares.

 

Total voting rights

 

The Company advises that it has, conditional on admission, allotted and issued 265,000 new fully paid ordinary shares of no par value in the Company (Ordinary Shares).

 

Application has been made to the UK Listing Authority for the admission of those 265,000 new Ordinary Shares to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's Main Market for listed securities and it is expected that dealings will commence on 15 October 2019. The new Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares in issue.

 

Following admission, the Company will have in issue a total of 265,587,398 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury.

 

Therefore, the total number of voting rights in the Company is 265,587,398 which may be used by shareholders or other persons as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

Notification of PDMR transaction

 

The Company advises that the 15,000 new fully paid shares issued on vesting of performance rights were issued to a person discharging managerial responsibilities (PDMR).

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Stuart Tarrant

2

 

Reason for the notification

a)

 

Position/status

 

PDMR (Chief Financial Officer)

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

 

Name

Danakali Limited

b)

 

LEI

5493004SQ5E5Q6VRT472

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Fully paid ordinary shares

 

 

 

Identification code

AU000000DNK9

 

 

b)

 

Nature of the transaction

 

Award of shares on the vesting of performance rights

 

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

15,000

 

d)

Aggregated information

- Aggregated volume

- Price

- Total

 

 

N/A

e)

 

Date of the transaction

 

8 October 2019

f)

Place of the transaction

Outside a trading venue

 

For more information, please contact:

 

Danakali

 

Niels Wage

Chief Executive Officer

+61 8 6189 8635

William Sandover

Head of Corporate Development & External Affairs

+61 499 776 998

 

Corporate Broker - Numis Securities

 

UK IR/PR - Instinctif Partners

John Prior / Matthew Hasson / James Black /

Paul Gillam

+44 (0)20 7260 1000

David Simonson / Sarah Hourahane / Dinara Shikhametova

danakali@instinctif.com

+44 (0)207 457 2020

 

 

 

 

 

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

 

 

Name of entity

 DANAKALI LTD

 

ABN

 56 097 904 302

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

(a) Ordinary shares

 

 

 

 

 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

(a) 250,000

(b) 15,000

 

 

 

 

 

3

Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

(a) Fully paid ordinary shares

(b) Fully paid ordinary shares

 

 

 

 

 

4

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

·; the date from which they do

·; the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·; the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

(a) Yes - fully paid ordinary shares

(b) Yes - fully paid ordinary shares

 

 

 

 

 

 

 

5

Issue price or consideration

 

(a) $0.543

(b) Nil

 

 

 

 

 

 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

 

 

 

(a) Exercise of unlisted options (Exercise price: $0.543; expiry 7 October 2019)

(b) Vesting of performance rights (15,000 Class 6)

 

 

 

 

 

 

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

Yes

 

 

 

 

 

 

6b

The date the security holder resolution under rule 7.1A was passed

27 May 2019

 

 

 

 

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

Nil

 

 

 

 

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

Nil

 

 

 

 

 

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

N/A

 

 

 

 

 

 

6f

Number of +securities issued under an exception in rule 7.2

(a) 250,000

(b) 15,000

 

 

 

 

 

 

6g

If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.

N/A

 

 

 

 

 

 

6h

If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

N/A

 

 

 

 

 

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

Capacity under L.R.7.1 is 35,028,502

Capacity under LR7.1A is 26,594,345

 

 

 

 

7

+Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

8 October 2019

 

 

 

 

 

 

 

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable)

265,587,398

 

Ordinary Shares

 

 

Number

+Class

9

Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable)

 

 

 

 

500,000

 

 

 

1,440,000

 

 

 

1,268,215

 

 

 

301,040

 

 

 

583,000

 

 

 

561,800

 

 

 

1,450,000

 

 

 

280,000

 

800,000

 

100,000

 

25,000

 

15,000

 

65,000

 

1,000,000

 

Unlisted Options exercisable at $0.912 each, expiring 11 May 2020 (Remuneration Options)

 

Unlisted Options exercisable at $0.94 each, expiring 19 May 2020 (Remuneration Options)

 

Unlisted Options exercisable at $1.031 each, expiring 24 January 2022 (Remuneration Options)

 

Unlisted Options exercisable at $1.031 each, expiring 24 January 2022 (Remuneration Options)

 

Unlisted Options exercisable at $1.108 each, expiring 13 March 2022 (Remuneration Options)

 

Unlisted Options exercisable at $1.119 each, expiring 28 March 2022 (Remuneration Options)

 

Unlisted Options exercisable at $1.114 each, expiring 30 May 2022 (Remuneration Options)

 

Performance Rights - Class 1

 

Performance Rights - Class 4

 

Performance Rights - Class 5

 

Performance Rights - Class 6

 

Performance Rights - Class 7

 

Performance Rights - Class 8

 

Performance Rights - Class 9

 

 

 

 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

N/A

       

 

 

 

Part 2 ‑ Pro rata issue

 

11

Is security holder approval required?

 

N/A

 

 

 

12

Is the issue renounceable or non-renounceable?

N/A

 

13

Ratio in which the +securities will be offered

N/A

 

 

 

 

14

+Class of +securities to which the offer relates

N/A

 

 

 

15

+Record date to determine entitlements

N/A

 

 

 

 

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

N/A

 

 

 

 

17

Policy for deciding entitlements in relation to fractions

N/A

 

 

 

18

Names of countries in which the entity has security holders who will not be sent new offer documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

N/A

 

 

 

19

Closing date for receipt of acceptances or renunciations

N/A

 

 

 

 

20

Names of any underwriters

 

N/A

 

 

 

 

21

Amount of any underwriting fee or commission

N/A

 

 

 

22

Names of any brokers to the issue

 

N/A

 

 

 

 

23

Fee or commission payable to the broker to the issue

N/A

 

 

 

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders

N/A

 

 

 

25

If the issue is contingent on security holders' approval, the date of the meeting

N/A

 

 

 

26

Date entitlement and acceptance form and offer documents will be sent to persons entitled

N/A

 

 

 

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

 

N/A

 

28

Date rights trading will begin (if applicable)

N/A

 

 

 

29

Date rights trading will end (if applicable)

N/A

 

 

 

 

30

 

How do security holders sell their entitlements in full through a broker?

N/A

 

 

 

 

31

 

How do security holders sell part of their entitlements through a broker and accept for the balance?

N/A

 

 

 

 

32

 

How do security holders dispose of their entitlements (except by sale through a broker)?

N/A

 

 

 

 

33

 

+Issue date

N/A

          

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of +securities

(tick one)

 

(a)

x

+Securities described in Part 1

 

 

 

 

(b)

 

All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

Entities that have ticked box 34(a)

 Additional securities forming a new class of securities

 

Tick to indicate you are providing the information or documents

 

 

 

35

 

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

 

 

 

36

 

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

 

 

 

37

 

A copy of any trust deed for the additional +securities

 

 

Entities that have ticked box 34(b)

 

38

Number of +securities for which +quotation is sought

 

N/A

 

 

 

 

 

39

+Class of +securities for which quotation is sought

 

N/A

 

 

 

 

 

40

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

·; the date from which they do

·; the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·; the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

N/A

 

 

 

 

 

41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

 

(if issued upon conversion of another +security, clearly identify that other +security)

 

N/A

 

 

 

 

 

 

 

Number

+Class

42

Number and +class of all +securities quoted on ASX (including the +securities in clause 38)

 

 

 

N/A

N/A

     

 

 

Quotation agreement

 

1 +Quotation of our additional +securities are in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2 We warrant the following to ASX.

 

·; The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

·; There is no reason why those +securities should not be granted +quotation.

 

·; An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

·; Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

·; If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

  9 October 2019

Sign here: ............................................................ Date: .........................

(Director/Company secretary)

 

 

Catherine Grant-Edwards

Print name: .........................................................

 

== == == == ==

 

 

 

Appendix 3B - Annexure 1

 

Calculation of placement capacity under rule 7.1 and rule 7.1A for +eligible entities

Introduced 01/08/12

 

Part 1

 

Rule 7.1 - Issues exceeding 15% of capital

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

Insert number of fully paid ordinary securities on issue 12 months before date of issue or agreement to issue

264,197,463

Add the following:

• Number of fully paid ordinary securities issued in that 12 month period under an exception in rule 7.2

• Number of fully paid ordinary securities issued in that 12 month period with shareholder approval

• Number of partly paid ordinary securities that became fully paid in that 12 month period

Note:

• Include only ordinary securities here - other classes of equity securities cannot be added

• Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

 

216,364 (fully paid ordinary shares issued 7 November 2018 on cashless exercise of options)

356,049 fully paid ordinary shares issued 24 July 2018 (ratified by shareholders 27 May 2019)

8,571 fully paid ordinary shares issued 20 December 2018 (ratified by shareholders 27 May 2019)

900,000 (fully paid ordinary shares issued 9 August 2019 on exercise of options)

250,000 (fully paid ordinary shares issued 8 October 2019 on exercise of options)

15,000 (fully paid ordinary shares issued 8 October 2019 on vesting of performance rights)

 

Subtract the number of fully paid ordinary securities cancelled during that 12 month period

 N/A

"A"

265,943,447

 

Step 2: Calculate 15% of "A"

"B"

0.15

[Note: this value cannot be changed]

Multiply "A" by 0.15

39,891,517

Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period not counting those issued:

• Under an exception in rule 7.2

• Under rule 7.1A

• With security holder approval under rule 7.1 or rule 7.4

Note:

• This applies to equity securities, unless specifically excluded - not just ordinary securities

• Include here (if applicable ) the securities the subject of the Appendix 3B to which this form is annexed

• It may be useful to set out issues of securities on different dates as separate line items

 

1,268,215 unlisted options (27 February 2019) (being 1,724,015 unlisted options initially issued less 455,800 unlisted options cancelled 7 June 2019)

583,000 unlisted options (26 March 2019)

561,800 unlisted options (18 April 2019)

1,000,000 performance rights (14 June 2019) (Class 9)

1,450,000 unlisted options (14 June 2019)

 

 

"C"

4,863,015

 

Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1

"A" x 0.15

Note: number must be same as shown in Step 2

39,591,517

Subtract "C"

Note: number must be same as shown in Step 3

4,863,015

Total ["A" x 0.15] - "C"

35,028,502

 

 

Part 2

 

Rule 7.1A - Additional placement capacity for eligible entities

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

"A"

Note: number must be same as shown in Step 1 of Part 1

265,943,447

Step 2: Calculate 10% of "A"

"D"

0.10

Note: this value cannot be changed

Multiply "A" by 0.10

26,594,345

Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

• This applies to equity securities - not just ordinary securities

• Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed

• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

• It may be useful to set out issues of securities on different dates as separate line items

Nil

"E"

Nil

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A

"A" x 0.10

Note: number must be same as shown in Step 2

26,594,345

Subtract "E"

Note: number must be same as shown in Step 3

Nil

Total ["A" x 0.10] - "E"

26,594,345

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUGGQPUUPBGCR
Date   Source Headline
10th Sep 20217:00 amRNSIssue of unlisted option & PDMR/PCA notifications
1st Sep 20217:02 amRNSTotal Voting Rights and Capital
1st Sep 20217:01 amRNSHalf-year Report
1st Sep 20217:00 amRNSChange to Board of Directors
11th Aug 20217:00 amRNSProposed Cancellation of London Listing
6th Aug 20217:56 amRNSIssue of Shares and Unlisted Options
2nd Aug 20217:00 amRNSTotal Voting Rights and Capital
30th Jul 20217:00 amRNSAmended Constitution
30th Jul 20217:00 amRNSResult of AGM
29th Jul 20217:00 amRNSQuarterly Activities Report and Appendix 5B
5th Jul 20217:00 amRNSCompany Presentation and Video
1st Jul 202111:06 amRNSNotice of AGM
1st Jul 20217:00 amRNSTotal Voting Rights
25th Jun 20219:31 amRNSNotification of PDMR transaction
25th Jun 20217:26 amRNSProposed issue of unlisted options
17th Jun 20217:00 amRNSColluli Project Update
11th Jun 20217:17 amRNSReport on Payments to Governments
1st Jun 20217:00 amRNSTotal Voting Rights and Capital
27th May 20217:00 amRNSColluli Project Update
21st May 20217:52 amRNSAppendix 3Y
21st May 20217:48 amRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSColluli Project - RO Plant Manufacturing Underway
12th May 20217:01 amRNSA$20.3M Placement Endorses Danakali's SOP Project
12th May 20217:00 amRNSCorrection of Announcement - Issue of Shares
6th May 20219:12 amRNSIssue of shares
6th May 20217:00 amRNSNotification of PDMR and PCA transactions
30th Apr 20219:53 amRNSAnnual Report to Shareholders
30th Apr 20217:00 amRNSQuarterly Activities Report and Appendix 5B
29th Apr 20217:05 amRNSCompany Presentation
29th Apr 20217:00 amRNSA$20.3M Placement to Advance Colluli
27th Apr 20217:00 amRNSASX Trading Halt and Proposed Fundraise
19th Apr 202110:15 amRNSAdviser Appointment
13th Apr 20217:00 amRNSResignation of CFO
6th Apr 20217:00 amRNSCorrection to Corporate Presentation
6th Apr 20217:00 amRNSTotal Voting Rights and Capital
31st Mar 20217:26 amRNSRelease of 2020 Financial Report
26th Mar 20217:00 amRNSExecutive Chairman remuneration
24th Mar 20219:31 amRNSIssue of unlisted options
24th Mar 20219:29 amRNSProposed issue of unlisted options
22nd Mar 20217:34 amRNSCompany Presentation
10th Mar 20217:00 amRNSClean energy zero carbon SOP
2nd Mar 20218:36 amRNSTotal Voting Rights and Capital
26th Feb 20217:00 amRNSAppointment of Executive Chairman and restructure
23rd Feb 20219:13 amRNSResponse to ASX price and volume query
15th Feb 20219:01 amRNSIssue of shares & options, PDMR/PCA transactions
11th Feb 20217:00 amRNSCompany Presentation
1st Feb 20217:53 amRNSTotal Voting Rights
29th Jan 20217:54 amRNSIssue of unlisted options
29th Jan 20217:50 amRNSProposed issue of securities
28th Jan 20217:37 amRNSQuarterly Report and Appendix 5B

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.